RPID logo

Rapid Micro Biosystems, Inc. Stock Price

NasdaqCM:RPID Community·US$141.9m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

RPID Share Price Performance

US$3.21
2.32 (262.30%)
59.9% undervalued intrinsic discount
US$8.00
Fair Value
US$3.21
2.32 (262.30%)
59.9% undervalued intrinsic discount
US$8.00
Fair Value
Price US$3.21
AnalystConsensusTarget US$8.00

RPID Community Narratives

AnalystConsensusTarget·
Fair Value US$8 59.9% undervalued intrinsic discount

Global Automation And Regulatory Emphasis Will Drive Pharmaceutical Modernization

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative

Recent RPID News & Updates

We Think Rapid Micro Biosystems (NASDAQ:RPID) Needs To Drive Business Growth Carefully

Jul 23
We Think Rapid Micro Biosystems (NASDAQ:RPID) Needs To Drive Business Growth Carefully

Rapid Micro Biosystems: Benefiting From Partnership With Merck; Initiating With 'Buy'

Jul 22

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

May 27
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate

Apr 21
We're Keeping An Eye On Rapid Micro Biosystems' (NASDAQ:RPID) Cash Burn Rate
User avatar

MilliporeSigma And Lonza Collaborations Will Expand Market Reach

The global agreement with MilliporeSigma is set to expand Growth Direct's market reach and potentially enhance supply chain efficiency, boosting future revenues.

Rapid Micro Biosystems, Inc. Key Details

US$30.3m

Revenue

US$28.0m

Cost of Revenue

US$2.3m

Gross Profit

US$46.4m

Other Expenses

-US$44.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-1.00
Gross Margin
7.53%
Net Profit Margin
-145.63%
Debt/Equity Ratio
0%

Rapid Micro Biosystems, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Flawless balance sheet with very low risk.

2 Risks
2 Rewards

About RPID

Founded
2006
Employees
163
CEO
Robert Spignesi
WebsiteView website
www.rapidmicrobio.com

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: -2.7%
  • 3 Months: 5.1%
  • 1 Year: 13.4%
  • Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.7%, driven by a pullback of 2.5% in the Information Technology sector. In the last year, the market is actually up 13%. Looking forward, earnings are forecast to grow by 15% annually. Market details ›